Elanco Animal Health Inc ELAN:NYSE

RT Quote | NYSE | USD
Last | 06/18/21 EDT
34.69quote price arrow down-1.03 (-2.88%)
Volume
5,336,293
52 week range
20.55 - 36.53

...

Loading . . .
  • Open35.47
  • Day High35.65
  • Day Low34.61
  • Prev Close34.69
  • 52 Week High36.53
  • 52 Week High Date05/21/21
  • 52 Week Low20.55
  • 52 Week Low Date06/26/20

Key Stats

  • Market Cap16.408B
  • Shares Out473.00M
  • 10 Day Average Volume4.40M
  • Dividend-
  • Dividend Yield-
  • Beta0.85
  • YTD % Change13.11

KEY STATS

  • Open35.47
  • Day High35.65
  • Day Low34.61
  • Prev Close34.69
  • 52 Week High36.53
  • 52 Week High Date05/21/21
  • 52 Week Low20.55
  • 52 Week Low Date06/26/20
  • Market Cap16.408B
  • Shares Out473.00M
  • 10 Day Average Volume4.40M
  • Dividend-
  • Dividend Yield-
  • Beta0.85
  • YTD % Change13.11

RATIOS/PROFITABILITY

  • EPS (TTM)-1.21
  • P/E (TTM)-28.67
  • Fwd P/E (NTM)33.55
  • EBITDA (MRQ)625.00M
  • ROE (MRQ)-7.80%
  • Revenue (MRQ)3.858B
  • Gross Margin (MRQ)50.67%
  • Net Margin (MRQ)-14.83%
  • Debt To Equity (MRQ)76.95%

EVENTS

  • Earnings Date07/28/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Elanco Animal Health Incorporated is an animal health company that develops, manufactures and markets products for companion and food animals. The Company offers its products under four primary categories, such as Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. It provides a range of parasiticide portfolios in the companion animal sector based on indications, species and formulations...
R. David Hoover
Chairman
Jeffrey Simmons
President
Todd Young
Chief Financial Officer
Dirk Ehle
Executive Vice President
Joyce Lee
Executive Vice President
Address
2500 Innovation Way N
Greenfield, IN
46140-9163
United States

Top Peers

SYMBOLLASTCHG%CHG
CTLT
Catalent Inc
108.61-1.95-1.76%
BMRN
Biomarin Pharmaceutical Inc
81.90-1.08-1.30%
RDY
Dr Reddy's Laboratories Ltd
71.50-0.59-0.82%
HZNP
Horizon Therapeutics PLC
94.61+2.47+2.68%
PRGO
Perrigo Company PLC
46.28-1.42-2.98%